Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies.
about
A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age.Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray.Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control.Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans.Non-immune immunoglobulins shield Schistosoma japonicum from host immunorecognition.Specific anti-glycan antibodies are sustained during and after parasite clearance in Schistosoma japonicum-infected rhesus macaques.Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyaninEvidence of long term benefit of morbidity reduction due to praziquantel treatment against schistosoma mansoni in kigungu fishing village in entebbe, Uganda.Molecular characterization of two Schistosoma mansoni proteins sharing common motifs with the vif protein of HIV-1.Glycoconjugates in host-helminth interactionsImmunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis.A theoretical framework for the immunoepidemiology of blocking antibodies to helminth infection.Molecular basis of host-parasite relationship: towards the definition of protective antigens.Characterization of Schistosoma mansoni monoclonal antibodies which block in-vitro killing: failure to demonstrate blockage of immunity in vivo.Humoral responses to a secretory Onchocerca volvulus protein: differences in the pattern of antibody isotypes to recombinant Ov20/OvS1 in generalized and hyperreactive onchocerciasis.Immunoglobulin M antibodies are not specific for serodiagnosis of human toxocariasis.Engineered human vaccines.Surface expression patterns of defined glycan antigens change during Schistosoma mansoni cercarial transformation and development of schistosomula.Functions of Antibodies.Schistosoma mansoni: immunolocalization of two different fucose-containing carbohydrate epitopes.Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni.The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil.Antibody isotype responses to the Schistosoma mansoni schistosomulum in the CBA/N mouse induced by different stages of the parasite life cycle.IgG subclass-associated differences in anti-schistosomal antibody specificity.Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells.Antibody isotypes in human schistosomiasis mansoni.Experimental Schistosoma bovis infection in goats. Circulating antigen and antibody responses to egg and adult worm antigens during infection and following treatment with praziquantel.The antibody responses to adult-worm antigens of Schistosoma haematobium, among infected and resistant individuals from an endemic community in southern Ghana.Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area.Evidence for enhancement of IgG1 subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity.The use of mouse/human chimaeric antibodies to investigate the roles of different antibody isotypes, including lgA2, in the killing of Schistosoma mansoni schistosomula by eosinophils
P2860
Q33607940-843B39EA-D4C6-40F4-820A-66BF01F3FFF4Q33876836-2C0C6BEE-D0FD-402F-8D20-A614994C9A5FQ34500892-C29CBF95-9E2E-4024-8FB5-438867B61362Q35500666-D433E423-4F91-41E3-852D-C483ADDC23A3Q35500689-F4348A38-F04D-4257-BC10-532535BFEB2DQ35989513-AFFE4B66-3813-4531-B63D-C4E6EFD61475Q36267300-2729AAAE-0719-45B5-ACCC-BC86BD3B358CQ36352492-2E7909A3-521C-45A2-BD74-2294C1BA4D97Q36398139-9BA39BC6-DF68-4499-A3F2-DBC057149C5CQ36736289-287DA9D4-9A11-432F-914F-68EE2F522C8AQ37126736-2AD2A0DF-F25E-4211-884D-A1E6D09C5EF0Q37191336-5C0ACCDF-7D89-48E3-AC8D-DB27AE82D46AQ37200815-EB7FFE62-0709-4772-934F-CD078AC3D4F0Q38572426-9A43B26A-4F53-45AF-A2B0-AEC1AB7E238CQ38749505-65A71FFD-CE0F-4909-AA28-EE382D1229B3Q38908592-8762CBC7-066E-4918-87E8-CE87ACAFA4F1Q39277126-99D7EC1C-8CB6-460D-B67E-C71A758FB23DQ39406512-AB31DEC8-A3E2-41B1-81AF-4F4111C4AC6DQ40754536-4123021A-5CBF-4D47-8087-3326A1276843Q41011195-3B454C20-BC24-4EA7-A47B-7E54A85A4E1CQ41741684-82C3D84D-FF14-480E-903B-A397ED6B096BQ42275200-6319732F-9C65-4632-B9A6-DCC3D9037128Q42938709-08A7B5DB-34BF-44E2-8567-B494DB7D9DC6Q44071866-A865BAF8-3B91-4BBD-810F-A66E53951FF4Q44374675-6A7583DC-8AAD-4790-B2C9-52522093C51CQ44423675-4F36985D-991E-41E5-8598-DDF0F3433771Q44988098-01E2AC35-E6EF-48FC-AF5A-578705F6B574Q46710649-84AEDBA6-16E2-426D-93F8-E40D312667B8Q46875282-21F870ED-B167-49B2-9C65-A7B5F647F2E4Q47229328-B7FFE26B-4EC8-4634-989B-25247887D439Q54172332-D036415F-FF40-48D9-B027-A16C6D65B79BQ54337052-488D7BB5-D0E6-4222-8DA8-CB4A07303826Q58312906-2A302F48-67EE-444E-AF0E-135F6A1257AE
P2860
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@ast
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@en
type
label
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@ast
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@en
prefLabel
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@ast
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@en
P2093
P2860
P921
P356
P1476
Immunity in human schistosomia ...... ms by IgM blocking antibodies.
@en
P2093
P2860
P304
P356
10.1084/JEM.164.5.1626
P407
P577
1986-11-01T00:00:00Z